Palantir's 96% Revenue Growth Hides a Slowing Sales Engine

Palantir grew revenue 96% year over year to $2.31 billion in the third quarter, yet the stock traded slightly down the next day. The reason: a measure of future enterprise sales declined from the prior quarter's record, and investors noticed what the company did not headline.

The Monday earnings report was strong enough that Palantir's own press release bragged the numbers were "crushing consensus expectations." Revenue crossed $2 billion for the first time in the company's history and beat analyst estimates of $2.18 billion. It also grew 20% from the previous quarter, roughly one-fifth more business in three months. Adjusted earnings per share came in at $0.44 versus the $0.41 analysts expected, and the company raised full-year revenue guidance. Takeaway: on every headline metric, Palantir outperformed.

The structural milestone was arguably bigger than the growth rate. U.S. commercial revenue reached $984 million, up 148% from the year-ago quarter, and surpassed U.S. government revenue — $953 million — for the first time ever. A company long defined by its government work now earns more from corporate America than from Washington.

Why are enterprises signing up so fast?

The pull, according to the company, is Palantir's AI software, which can run frontier models and custom-train open-weight models securely without sharing corporate data or business processes with outside AI labs. Palantir also offers what is now called "forward-deployed" software engineering, where its engineers work inside customer environments to customize the products. The pitch: powerful AI with none of the data leakage.

But the speed of those signings carries a catch. CEO Alex Karp told Wall Street analysts on the quarterly call: "What Ryan and I are seeing on the front line and in commercial is this much quicker interaction, much quicker to deployment, shorter duration of the contract but then an ability to expand that contract dramatically." Faster trials, shorter commitments. The same corporate agility that accelerates adoption also makes cancellation easier — corporations are bypassing their usual procurement bureaucracy to try AI quickly, and they can exit quickly too.

Karp dismissed the risk in characteristically colorful terms. "We've gone from being the most attractive person in the physics department to being the captain of the football team, kind of thing," he said, describing the influx of prospective corporate customers. "Conversely, you know, once you go Palantir, you don't go back, and that's just that's how it is, and you see it in our numbers." Confidence, however, is not a contract duration.

What do the numbers actually show?

The figures complicate Karp's assurance. Palantir closed $1.46 billion in total contract value from U.S. enterprises in the quarter. That is a hefty sum — but a decline from the record $2.13 billion of enterprise TCV in the previous quarter, a drop of roughly 31%. One quarter is not a trend, yet it suggests decelerating enterprise sales at exactly the moment the commercial segment became the company's growth story. Takeaway: the deals are getting shorter at the same time the pipeline is getting thinner.

What happens next quarter?

The fourth-quarter report will test whether Palantir has solidified its position as a rising U.S. enterprise AI provider. Historically, many enterprises sign their largest technology purchases in the final quarter of the year, which gives the company a natural shot at reversing the TCV decline. Management is betting on it: Palantir raised its guidance for U.S. commercial revenue to "in excess of $3.559 billion, representing a growth rate of at least 143%." If short-term trials convert into expanded contracts the way Karp predicts, that guidance holds. If they lapse as quickly as they were signed, the lukewarm stock reaction will look prescient.